Our aim was to review clinical outcome and patient satisfaction after cataract surgery to obtain spectacle independence following multifocal intraocular lens (IOL) implantation. A prospective case-series study was designed to evaluate the safety and efficacy of the Hanita FullRange pseudophakic multifocal intraocular lens in patients with programmed cataract surgery, performed between October 2017 and May 2018, with follow-up after 12 months. Manifest refraction spherical equivalent (SE), SE refractive accuracy, uncorrected distance (UDVA), intermediate (UIVA) and near visual acuity (UNVA) and a binocular defocus curve were evaluated. In addition, a short “satisfaction questionnaire” was developed. Surgeries were performed without viscoelastic substance. The corneal endothelial cell density (ECD), central corneal thickness (CCT) and intraocular pressure (IOP) were also evaluated. A total of 480 eyes of 240 patients with mean ± standard deviation (SD) of age of 75 ± 6.12 years were included. The mean ± standard deviation (SD) of preoperative SE was 2.0 ± 2.18 D (range; -5.50 to 4.75) which decreased to -0.04 ± 0.28 D (range; -0.75 to 0.625) 12 months after surgery. Regarding SE refractive accuracy 82.9 % of eyes obtained SE values between -0.5 and 0.5 D. There was no loss of lines of vision and 98.3% of patients achieved UDVA between 20/20 and 20/25. The UNVA (binocular) obtained was J1 for 72.5% and J2 for 27.5% of patients. Regarding defocus curve, 0.04 logMAR for -3.0 D, 0.09 logMAR for -1.5 D and 0.03 logMAR for 0 D was achieved. The mean CCT was increased by 6.62 ± 2.79 micrometer (1.24%), the mean ECD was decreased by 226.08 ± 11.63 cell/mm2 (9.00 %) and the IOP remained stable one year after surgery. In response to the satisfaction questionnaire, 92% of patients stated that they had obtained spectacle independence. Finally, spectacle independence was achieved in most of the cases, with a high level of patient satisfaction one year after implantation of a FullRange IOL. No complications were detected. We concluded that the refractive efficacy of FullRange multifocal IOL was proved in majority of cases. A large follow up period is necessary in future studies to confirm the results. KEY
Medical Hypothesis, Discovery & Innovation Ophthalmology Journal
Spectacle Independence After Cataract Surgery: A Prospective Study With a Multifocal Intraocular Lens
German R Bianchi, MD
(2020)
A study of 240 patients who received the FullRange multifocal IOL showed excellent visual outcomes, with 98.3% achieving 20/20 to 20/25 distance vision and 92% reporting spectacle independence one year after cataract surgery. Refractive accuracy was high, with 82.9% of eyes within ±0.5 D of target refraction. Patient satisfaction was notable, with strong near and intermediate visual performance and no reported complications. Future studies with longer follow-up will help further confirm these results.
STAY INFORMED
Signup to get the first look at new products, publications, and events
Related publications
BMC Ophthalmology
Gustavo Goldman
This study examined the optical performance and safety of a newly designed multifocal intraocular lens (IOL) with five focal points (two additional "intensifiers") for cataract and presbyopia management. Conducted in Buenos Aires and Ramos Mejia, Argentina, the prospective, non-randomized observational study included 31 patients (61 eyes) who received bilateral implantation between March 2020 and November 2021. At the 3-month follow-up, all eyes achieved an uncorrected distance visual acuity (UCDVA) of at least 0.15 logMAR, with 93% achieving 0.1 logMAR and 44% achieving 0.0 logMAR. For intermediate vision at 80 cm, 98% of eyes achieved at least 0.1 logMAR, and 79% reached 0.0 logMAR. The results highlight the new multifocal IOL’s efficacy, particularly for intermediate and near vision, with high rates of spectacle independence and patient satisfaction.
HIGHLIGHTS OF OPHTHALMOLOGY
Kepa Balparda, MSc PhD
This study aimed to assess the short-term refractive and visual outcomes following the implantation of the Hanita Intensity SL pentafocal intraocular lens (IOL) in patients with presbyopia. In a retrospective observational review, 20 eyes from 10 patients (70% female) who underwent immediate sequential bilateral surgery were evaluated over three months. Results showed that 100% of patients achieved visual acuity of 20/25 or better for both near and far distances, and 20/40 or better for intermediate distances. The defocus curve indicated excellent visual performance from infinity to approximately 33 cm, allowing functional vision at all distances. Additionally, all patients reported complete independence from glasses. These findings suggest that the Hanita Intensity SL IOL is a safe and effective option for achieving spectacle independence in presbyopic patients.
JRS, Journal of Refractive Surgery
Dr. Bellucci
A clinical study comparing the new Intensity pentafocal IOL and a trifocal IOL showed that the Intensity IOL provides superior intermediate vision and a flatter defocus curve, with comparable distance and near vision. Patients reported fewer optical disturbances, such as glare and halos, with the Intensity IOL. Further research will clarify the specific benefits of the pentafocal design.